Muneyuki Masuda

Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.

Muneyuki Masuda, Masumi Suzui, Ryuji Yasumatu et al. · PubMed · 2002 · 379 citations

Hnscc Cells, Signal Transducers, Immunology +20

Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.

Muneyuki Masuda, Masumi Suzui, I. Bernard Weinstein · PubMed · 2001 · 319 citations

Chemoprevention Strategy, Pathology, Cell Death +19

Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim et al. · Journal of Experimental Therapeutics and Oncology · 2002 · 232 citations

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim et al. · PubMed · 2003 · 156 citations

Breast Oncology, Chemoprevention Strategy, Downstream Signaling Pathways +19

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Masumi Suzui, Muneyuki Masuda, Jin T. E. Lim et al. · PubMed · 2002 · 123 citations

Chemoprevention Strategy, Acyclic Retinoid, Cyclin D1 +18